Search results
Results from the WOW.Com Content Network
Dengue fever is a mosquito-borne disease caused by dengue virus, prevalent in tropical and subtropical areas. It is frequently asymptomatic ; if symptoms appear, they typically begin 3 to 14 days after infection.
Widespread non-communicable diseases such as cardiovascular disease and cancer are not included. An epidemic is the rapid spread of disease to a large number of people in a given population within a short period of time; in meningococcal infections , an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered ...
Dengue viruses (DEN-1, DEN-2, DEN-3 and DEN-4) – Flaviviruses: Dengue fever: Clinical diagnosis Treatment depends on the symptoms. Yes: Green algae Desmodesmus armatus Desmodesmus infection No Dientamoeba fragilis: Dientamoebiasis: No Corynebacterium diphtheriae: Diphtheria: Laboratory criteria Isolation of C. diphtheriae culture ...
The number of dengue cases reported in the Americas exceeded 9.7 million during the period between January 1 and June 24, twice as many as in all of 2023, the CDC said, adding that a higher-than ...
Most dengue fever patients recover in a week, but in severe cases the disease can be life-threatening and require hospitalization since it can result in shock, internal bleeding and even death.
Varicella voster infection- chickenpox, shingles, and unspecified Chickenpox: Chickenpox (regional) Chickenpox (i.e., varicella) - morbidity and deaths only Chikungunya fever: Chikungunya fever: Chikungunya fever: Human coronavirus with pandemic potential (COVID-19/SARS-CoV-2) COVID-19: Dengue fever: Dengue fever: Dengue fever: Dengue fever ...
The Centers for Disease Control released a health advisory on Tuesday, alerting health providers about the surge in dengue fever cases. The virus is spreading worldwide, but specifically ...
In December 2018, Dengvaxia was approved in the European Union. [7]In May 2019, Dengvaxia was approved in the United States as the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3, and 4) in people ages nine through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.